$NARI News
Last published 11mo ago
- 11mo agoNARIInari Medical, Inc. et al. vs Imperative Care, Inc. - AIA Trial, Institution GrantedUS Patent Trial and Appeal Board
- 11mo agoNARIInari Medical, Inc. et al. vs Imperative Care, Inc. - AIA Trial, Institution GrantedUS Patent Trial and Appeal Board
- 11mo agoNARIInari Medical, Inc. et al. vs Imperative Care, Inc. - AIA Trial, Institution GrantedUS Patent Trial and Appeal Board
- 1y agoNARIInari Medical, Inc. et al. vs Imperative Care, Inc. - AIA Trial, Institution GrantedUS Patent Trial and Appeal Board
- 1y agoNARIInari Medical, Inc. et al. vs Imperative Care, Inc. - AIA Trial, Institution GrantedUS Patent Trial and Appeal Board
- 1y agoNARIInari Medical, Inc. vs Imperative Care, Inc. - AIA Trial, Institution GrantedUS Patent Trial and Appeal Board
- 1y agoNARIInari Medical, Inc. vs Imperative Care, Inc. - AIA Trial, Institution GrantedUS Patent Trial and Appeal Board
- 1y agoNARISYKStryker completes acquisition of Inari Medical, Inc., providing entry into the high-growth peripheral vascular segmentGlobeNewswirePortage, Michigan, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK), a global leader in medical technologies, announced today that it has completed the acquisition of Inari Medical, Inc. (NASDAQ:NARI), a company
- 1y agoNARIInari Medical, Inc. vs Imperative Care, Inc. - AIA Trial, Institution DeniedUS Patent Trial and Appeal Board
- 1y agoAVAVFNANARITGIKuehn Law Encourages FNA, TGI, AVAV, and NARI Investors to Contact Law FirmGlobeNewswireNEW YORK, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating potential claims related to the below-listed proposed mergers. Kuehn Law may seek additional disclosures
- 1y agoNARIINARI MEDICAL, INC. vs Imperative Care, Inc. - AIA Trial, Institution GrantedUS Patent Trial and Appeal Board
- 1y agoMASINARIOMMasimo Announces Leadership TransitionBusiness WireKatie Szyman Appointed Chief Executive Officer and to Board of Directors Interim CEO Michelle Brennan Named Chairman of Masimo's Board Today the Board of Directors (the "Board") of Masimo (NASDAQ:MASI), a leading
- 1y agoNARISYKStryker commences tender offer for all outstanding shares of common stock of Inari Medical, Inc.GlobeNewswirePortage, Michigan, Jan. 17, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) today announced that it is commencing, through a wholly owned subsidiary, Eagle 1 Merger Sub, Inc., a cash tender offer to purchase all of the
- 1y agoNARISYKStryker announces definitive agreement to acquire Inari Medical, Inc., providing entry into high-growth peripheral vascular segmentGlobeNewswirePortage, Michigan and Irvine, California, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK), a global leader in medical technologies, announced today a definitive agreement to acquire all of the issued and
- 1y agoNARIInari Medical to Present at the J.P. Morgan Healthcare ConferenceGlobeNewswireIRVINE, Calif., Jan. 03, 2025 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ:NARI), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other vascular
- 1y agoNARIInari Medical Announces Reimbursement Approval for ClotTriever® Thrombectomy System in Japan and New Distribution Partnership with Medikit Co., Ltd.GlobeNewswireIRVINE, Calif., Dec. 02, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ:NARI) ("Inari"), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other
- 1y agoNARIInari Medical Announces Joint Venture in Greater ChinaGlobeNewswireIRVINE, Calif., Dec. 02, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ:NARI) ("Inari"), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other
- 2y agoNARIInari Medical to Participate in the Jefferies London Healthcare ConferenceGlobeNewswireIRVINE, Calif., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ:NARI) ("Inari"), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other
- 2y agoNARIPEERLESS Results Show Superiority of FlowTriever® Compared to Catheter-Directed Thrombolytics for Intermediate-Risk Pulmonary EmbolismGlobeNewswireIRVINE, Calif., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ:NARI) ("Inari"), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other
- 2y agoNARIInari Medical, Inc. (NARI) Q3 2024 Earnings Call TranscriptEarnings Call Transcripts
- 2y agoNARIInari Medical Reports Third Quarter 2024 Financial ResultsGlobeNewswireIRVINE, Calif., Oct. 28, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ:NARI) ("Inari"), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other
- 2y agoNARIOkami Medical Announces Closing Of $32.5M FinancingPR NewswireOkami Medical today announced the closing of a $32.5M financing led by new investor Vensana Capital and joined by existing investors including U.S....
- 2y agoNARIInari Medical Announces Partnership with AVF and NBCA on DEFIANCE TrialGlobeNewswireIRVINE, Calif., Oct. 15, 2024 (GLOBE NEWSWIRE) -- In recognition of World Thrombosis Day, Inari Medical, Inc. (NASDAQ:NARI) ("Inari") a medical device company with a mission to treat and transform the lives of patients
- 2y agoNARIInari Medical to Host Analyst and Investor Meeting Following PEERLESS RCT PresentationGlobeNewswireIRVINE, Calif., Oct. 07, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ:NARI) ("Inari"), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other
- 2y agoNARIInari Medical to Announce Third Quarter 2024 Financial ResultsGlobeNewswireIRVINE, Calif., Oct. 07, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ:NARI) ("Inari"), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other
- 2y agoNARIInari Medical Announces PEERLESS Data to be Presented During the Late-Breaking Clinical Trial Sessions at TCT 2024GlobeNewswireIRVINE, Calif., Aug. 29, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ:NARI) ("Inari"), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other
- 2y agoNARIInari Medical to Present at Upcoming Investor ConferencesGlobeNewswireIRVINE, Calif., Aug. 21, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ:NARI) ("Inari"), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other
- 2y agoNARIInari Medical, Inc. (NARI) Q2 2024 Earnings Call TranscriptEarnings Call Transcripts
- 2y agoNARIInari Medical Announces Chief Financial Officer Retirement and Succession PlanGlobeNewswireIRVINE, Calif., July 30, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ:NARI) ("Inari"), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other
- 2y agoNARIInari Medical Reports Second Quarter 2024 Financial ResultsGlobeNewswireIRVINE, Calif., July 30, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ:NARI) ("Inari"), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other
- 2y agoNARIInari Medical to Announce Second Quarter 2024 Financial ResultsGlobeNewswireIRVINE, Calif., July 16, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ:NARI) ("Inari"), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other
- 2y agoNARISHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of InariPR NewswireFaruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Inari Medical, Inc. ("Inari" or the...
- 2y agoNARIInvestors in Inari Medical, Inc. Should Contact The Gross Law Firm Before July 12, 2024 to Discuss Your Rights - NARIPR NewswireThe Gross Law Firm issues the following notice to shareholders of Inari Medical, Inc. (NASDAQ: NARI). Shareholders who purchased shares of NARI...
- 2y agoNARIInari Medical, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - NARIPR NewswireThe Gross Law Firm issues the following notice to shareholders of Inari Medical, Inc. (NASDAQ: NARI). Shareholders who purchased shares of NARI...
- 2y agoNARIInari Medical, Inc. Sued for Securities Law Violations - Contact The Gross Law Firm Before July 12, 2024 to Discuss Your Rights - NARIPR NewswireThe Gross Law Firm issues the following notice to shareholders of Inari Medical, Inc. (NASDAQ: NARI). Shareholders who purchased shares of NARI...
- 2y agoALCNARIOCSRXSTOculis Publishes Results of 2024 Annual General Meeting and Announces Appointments to its Board of Directors and Scientific Advisory BoardGlobeNewswireShareholders approved all agenda items and proposals of the Board of DirectorsRobert K. Warner, M.B.A. and Arshad M. Khanani, M.D., M.A., FASRS elected as members of the Board of DirectorsBaruch D. Kuppermann, M.D.,
- 2y agoNARIThe Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of July 12, 2024 in Inari Medical, Inc. Lawsuit – NARIGlobeNewswireNEW YORK, May 28, 2024 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Inari Medical, Inc. (NASDAQ:NARI). Shareholders who purchased shares of NARI during the class period listed
- 2y agoNARIInari Medical Files Patent Infringement Lawsuit Against Imperative Care and Truvic MedicalGlobeNewswireIRVINE, Calif., May 23, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ:NARI) ("Inari"), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other
- 2y agoNARILowey Dannenberg, P.C. is Investigating Inari Medical Inc. ("Inari" or the "Company") (NASDAQ:NARI) for Potential Violations of the Federal Securities Laws and Encourages Investors with more than $50,000 in Losses to Contact the FirmGlobeNewswireNEW YORK, May 07, 2024 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, is investigating Inari Medical Inc. ("Inari" or the "Company") (NASDAQ:NARI) for
- 2y agoNARIInari Medical to Participate in the 2024 Bank of America Securities Healthcare ConferenceGlobeNewswireIRVINE, Calif., May 06, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ:NARI) ("Inari"), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other
- 2y agoNARILowey Dannenberg, P.C. is Investigating Inari Medical Inc. ("Inari" or the "Company") (NASDAQ:NARI) for Potential Violations of the Federal Securities Laws and Encourages Investors with more than $50,000 in Losses to Contact the FirmGlobeNewswireNEW YORK, May 03, 2024 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, is investigating Inari Medical Inc. ("Inari" or the "Company") (NASDAQ:NARI) for
- 2y agoNARIInari Medical, Inc. (NARI) Q1 2024 Earnings Call TranscriptEarnings Call Transcripts
- 2y agoNARIInari Medical Reports First Quarter 2024 Financial ResultsGlobeNewswireIRVINE, Calif., April 30, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ:NARI) ("Inari"), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other
- 2y agoNARILowey Dannenberg, P.C. is Investigating Inari Medical Inc. ("Inari" or the "Company") (NASDAQ:NARI) for Potential Violations of the Federal Securities Laws and Encourages Investors with more than $50,000 in Losses to Contact the FirmGlobeNewswireNEW YORK, April 22, 2024 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, is investigating Inari Medical Inc. ("Inari" or the "Company") (NASDAQ:NARI)
- 2y agoNARILowey Dannenberg, P.C. is Investigating Inari Medical Inc. ("Inari" or the "Company") (NASDAQ:NARI) for Potential Violations of the Federal Securities Laws and Encourages Investors with more than $50,000 in Losses to Contact the FirmGlobeNewswireNEW YORK, April 19, 2024 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, is investigating Inari Medical Inc. ("Inari" or the "Company") (NASDAQ:NARI)
- 2y agoNARIInari Medical to Announce First Quarter 2024 Financial ResultsGlobeNewswireIRVINE, Calif., April 17, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ:NARI) ("Inari"), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other
- 2y agoNARILowey Dannenberg, P.C. is Investigating Inari Medical Inc. ("Inari" or the "Company") (NASDAQ:NARI) for Potential Violations of the Federal Securities Laws and Encourages Investors with more than $50,000 in Losses to Contact the FirmGlobeNewswireNEW YORK, April 15, 2024 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, is investigating Inari Medical Inc. ("Inari" or the "Company") (NASDAQ:NARI)
- 2y agoNARIInari Medical Announces the Release of 2023 Ethos and Sustainability ReportGlobeNewswireIRVINE, Calif., April 11, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ:NARI) ("Inari"), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other
- 2y agoNARILowey Dannenberg, P.C. is Investigating Inari Medical Inc. ("Inari" or the "Company") (NASDAQ:NARI) for Potential Violations of the Federal Securities Laws and Encourages Investors with more than $50,000 in Losses to Contact the FirmGlobeNewswireNEW YORK, April 11, 2024 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, is investigating Inari Medical Inc. ("Inari" or the "Company") (NASDAQ:NARI)
- 2y agoNARIInari Medical Strengthens Senior Leadership Team with Addition of Two ExecutivesGlobeNewswireIRVINE, Calif., April 02, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ:NARI) ("Inari"), today announced the appointment of Tim Benner as Senior Vice President of U.S. Sales and Dr. Andrew Niekamp as Vice